Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Cancer|January 1, 1985
A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancerH W Bruckner, G E Dinse, T E Davis, et al.
Medical and Pediatric Oncology|January 1, 1979
Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up studyD M Hayes, T F Pajak, V Rege, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancerS G Taylor, M W Knuiman, L A Sleeper, et al.
Cancer|June 1, 1982
Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Medical and Pediatric Oncology|January 1, 1975
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myelomaJ Cuttner, L R Wasserman, G Martz, et al.
Breast Cancer Research and Treatment|June 29, 2002
Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancerA Buzdar, D Hayes, A El-Khoudary, et al.
Cancer|January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, L A Leone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetateP Dombernowsky, I Smith, G Falkson, et al.
Cancer|February 1, 1978
Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapseF H Kung, W L Nythan, J Cuttner, et al.
Cancer|August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Pageof 20